Alexandria Real Estate Equities, Inc., Landlord and Developer of Choice to the Life Science Industry, is a publicly-traded real estate investment trust focused principally on the ownership, operation, management, selective redevelopment, development and acquisition of life science properties. Our properties are designed and improved for lease primarily to institutional, pharmaceutical, biotechnology, medical device, life science product, service, biodefense and translational medicine entities, as well as governmental agencies. Alexandria Real Estate Equities Inc. has a market cap of $2.36 billion; its shares were traded at around $59.97 with a P/E ratio of 9.7 and P/S ratio of 5.2. The dividend yield of Alexandria Real Estate Equities Inc. stocks is 2.4%. Alexandria Real Estate Equities Inc. had an annual average earning growth of 8.9% over the past 5 years.
ARE is in the portfolios of Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, David Dreman of Dreman Value Management, Ron Baron of Baron Funds, Chris Davis of Davis Selected Advisers, Kenneth Fisher of Fisher Asset Management, LLC.
Insiders' Positions with ARE
- Sell:: CEO Joel S Marcus sold 52,904 shares of ARE stock on 11/13/2009 at the average price of 58.77, the price of the stock has increased by 2.04% since
- Sell:: CEO Joel S Marcus sold 15,000 shares of ARE stock on 11/11/2009 at the average price of 59.96, the price of the stock has increased by 0.02% since
- Sell:: CEO Joel S Marcus sold 5,000 shares of ARE stock on 08/20/2009 at the average price of 50, the price of the stock has increased by 19.94% since
- Sell:: CEO Joel S Marcus sold 11,300 shares of ARE stock on 08/14/2009 at the average price of 50, the price of the stock has increased by 19.94% since
- Sell:: CEO Joel S Marcus sold 3,700 shares of ARE stock on 08/13/2009 at the average price of 50, the price of the stock has increased by 19.94% since
Insiders' Positions with ARE
- Sell:: CFO Dean A Shigenaga sold 5,000 shares of ARE stock on 11/10/2009 at the average price of 60.14, the price of the stock has decreased by 0.28% since
- Sell:: CFO Dean A Shigenaga sold 5,000 shares of ARE stock on 08/11/2009 at the average price of 49.25, the price of the stock has increased by 21.77% since
Insiders' Positions with ARE
- Sell:: Director James H Richardson sold 2,500 shares of ARE stock on 11/13/2009 at the average price of 59.34, the price of the stock has increased by 1.06% since
- Sell:: Director Alan G Walton sold 5,500 shares of ARE stock on 11/13/2009 at the average price of 59.42, the price of the stock has increased by 0.93% since
- Sell:: Director James H Richardson sold 11,787 shares of ARE stock on 11/11/2009 at the average price of 60.43, the price of the stock has decreased by 0.76% since
- Sell:: Director Alan G Walton sold 2,500 shares of ARE stock on 11/10/2009 at the average price of 59.36, the price of the stock has increased by 1.03% since
- Sell:: Director James H Richardson sold 3,000 shares of ARE stock on 08/20/2009 at the average price of 49.48, the price of the stock has increased by 21.2% since
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |